Literature DB >> 3309813

[Intraocular penetration of pefloxacin in man and rabbit. The aqueous humor and vitreous body].

F Denis1, M Mounier, J P Adenis.   

Abstract

Intraocular distribution of pefloxacin was evaluated in 64 patients undergoing ocular surgery and in 4 rabbits after experimental infection of one eye by Staphylococcus aureus. Patients were perfused during one hour either with 800 or 400 mg of pefloxacin. Samples (serum, aqueous humor, vitreous fluid) were collected 0, 1, 2, 3, 4, 5 or 12 h after the end of antibiotic administration. Antibiotic levels were measured using a standard microbiological assay. The aqueous humor levels remained stables until 12 h, but were higher with a posology of 800 mg (mean level: 2.66 mg/l) than with a posology of 400 mg (mean level: 0.66 mg/l). The ratio between vitreous and serum concentrations ranged from 8 at 12% with 400 mg and from 2 to 36% with perfusion of 800 mg. The efficacy of pefloxacin treatment is demonstrated in the experimental infection of rabbits eyes.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3309813

Source DB:  PubMed          Journal:  Pathol Biol (Paris)        ISSN: 0369-8114


  4 in total

Review 1.  Pefloxacin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  J P Gonzalez; J M Henwood
Journal:  Drugs       Date:  1989-05       Impact factor: 9.546

2.  Ocular kinetics of pefloxacin after intramuscular administration in albino and pigmented rabbits.

Authors:  I Cochereau-Massin; J Bauchet; F Faurisson; J M Vallois; P Lacombe; J J Pocidalo
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191

3.  Intravitreal penetration of oral pefloxacin in humans.

Authors:  M Oncel; G A Peyman
Journal:  Int Ophthalmol       Date:  1993-08       Impact factor: 2.031

4.  Comparative pharmacokinetics of ciprofloxacin, ofloxacin and pefloxacin in human aqueous humour.

Authors:  H Giamarellou; D Kanellas; E Kavouklis; G Petrikkos; L Gabriel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1993-04       Impact factor: 3.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.